TC BioPharm Files August 2025 6-K Report
Ticker: TCBWF · Form: 6-K · Filed: Aug 5, 2025 · CIK: 1872812
Sentiment: neutral
Topics: 6-K, regulatory-filing, biopharmaceutical
TL;DR
TC BioPharm filed its August 6-K, just standard company info.
AI Summary
TC BioPharm (Holdings) plc, a biopharmaceutical company, filed a Form 6-K on August 5, 2025. The filing is a report of a foreign private issuer for the month of August 2025. The company is incorporated in Scotland, United Kingdom, with its principal executive offices located at Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR.
Why It Matters
This filing provides routine updates for investors regarding TC BioPharm's status as a foreign private issuer. It confirms their reporting obligations and basic company information.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain significant new financial or operational information that would typically alter risk.
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Registrant
- August 5, 2025 (date) — Filing Date
- Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR (location) — Principal Executive Offices
- Scotland, United Kingdom (location) — Incorporation Location
FAQ
What type of filing is this for TC BioPharm?
This is a Form 6-K, a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The filing was made on August 5, 2025.
Where are TC BioPharm's principal executive offices located?
The principal executive offices are located at Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom.
Does TC BioPharm file annual reports under Form 20-F or 40-F?
TC BioPharm indicated that it files annual reports under cover of Form 20-F.
What is the SIC code for TC BioPharm?
The Standard Industrial Classification (SIC) code for TC BioPharm is 2836, for Biological Products (no diagnostic substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 5, 2025 regarding TC BioPharm (Holdings) plc (TCBWF).